TGTX TG THERAPEUTICS, INC.: institutional ownership and insider trading
470 funds reported holding $6.87B of TG THERAPEUTICS, INC. in their latest 13F filings; in Q2 2026 funds net bought $302M, with 104 new positions and 34 funds selling out; over the last 12 months insiders bought $0 and sold $438K on the open market.
Famous investors holding TGTX
- Two Sigma (Two Sigma Investments): $138M, 0.1% of the portfolio
- Ray Dalio (Bridgewater Associates): $23.6M, 0.1% of the portfolio
- D. E. Shaw (D. E. Shaw & Co.): $191M, 0.1% of the portfolio
- Renaissance Technologies (Renaissance Technologies): $37.3M, 0.1% of the portfolio
- Ken Griffin (Citadel Advisors): $68.2M, 0.0% of the portfolio
- Izzy Englander (Millennium Management): $15.5M, 0.0% of the portfolio
Largest institutional holders of TGTX
- BlackRock, Inc. (BLK) — $1.21B
- VANGUARD GROUP INC — $472M
- VANGUARD PORTFOLIO MANAGEMENT LLC — $438M
- STATE STREET CORP (STT, STT-PG) — $428M
- VANGUARD CAPITAL MANAGEMENT LLC — $338M
- GEODE CAPITAL MANAGEMENT, LLC — $200M
- D. E. Shaw & Co., Inc. — $191M
- Soleus Capital Management, L.P. — $161M
- PRICE T ROWE ASSOCIATES INC /MD/ — $152M
- Clearbridge Investments, LLC — $146M
Recent TGTX insider trades
- Sep 10, 2026: Charney Laurence N sold 5,000 shares ($275K)
- Nov 24, 2025: Echelard Yann sold 5,000 shares ($163K)
- Sep 11, 2025: Lonial Sagar sold 20,852 shares ($672K)
- Jun 13, 2025: Echelard Yann sold 10,000 shares ($369K)
5%+ owners
- Vanguard Portfolio Management: 5.3% (Schedule 13G, filed Apr 29, 2026)